This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Sandoz moves to dismiss three US antitrust complaints over generic drugs

( March 2, 2026, 18:02 GMT | Official Statement) -- MLex Summary: Sandoz moved to dismiss US antitrust claims brought by Walmart, United Healthcare Services, and Southwest Airlines over generic drug prices, arguing that the amended complaints continue to rely on inapplicable copycat allegations, adding only sparse assertions about Sandoz that do not come close to stating a claim. Sandoz also said that the court lacks jurisdiction over it because it is a Swiss company that does not distribute generic pharmaceuticals in the US.See attached files....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login